Drug companies in US spent millions pushing for weight loss drug approvals, investigative report finds
BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2138 (Published 22 April 2015) Cite this as: BMJ 2015;350:h2138- Michael McCarthy
- 1Seattle
Since 2010, makers of diet drugs have spent more than $60m (£40m; €56m) on lobbying, medical society sponsorships, and payments to physicians to get their weight loss drugs to the market, says a joint investigative report by the medical news website MedPage Today and the Milwaukee Journal Sentinel.1
The size of the market is considerable: the US Centers for Disease Control and Prevention has estimated that over a third (34.9%; 78.6 million) of US adults are obese. The new report alleged that many efforts by drug companies have been aimed at pressuring the US Food and Drug …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.